NasdaqCM - Nasdaq Real Time Price USD
Cocrystal Pharma, Inc. (COCP)
1.3635
-0.0365
(-2.61%)
As of 11:16:26 AM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
FROST PHILLIP MD ET AL Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Oct 9, 2024 | 1,346,940 |
HASSAN FRED Director | Stock Award(Grant) | Oct 9, 2024 | 1,023,300 |
JAPOUR ANTHONY J M.D. Director | Stock Award(Grant) | Oct 9, 2024 | 14,924 |
KORNBERG ROGER D Director | Stock Award(Grant) | Oct 9, 2024 | 67,878 |
LEE SAM Chief Executive Officer | Stock Award(Grant) | Oct 9, 2024 | 76,355 |
MARTIN JAMES JOSEPH Chief Executive Officer | Stock Award(Grant) | Oct 9, 2024 | 40,569 |
PFENNIGER RICHARD C JR Director | Stock Award(Grant) | Oct 9, 2024 | 11,400 |
RUBIN STEVEN DANIEL Director | Stock Award(Grant) | Oct 9, 2024 | 2,660,240 |
Related Tickers
ASBPW Aspire Biopharma Holdings, Inc.
0.0600
+20.00%
ICUCW SeaStar Medical Holding Corporation
0.0385
+18.46%
VRAX Virax Biolabs Group Limited
1.0300
+7.38%
XRTX.V XORTX Therapeutics Inc.
1.5000
+4.17%
ANL Adlai Nortye Ltd.
2.0000
+9.29%
INTS Intensity Therapeutics, Inc.
1.3810
-23.70%
XBIO Xenetic Biosciences, Inc.
2.5550
+6.90%
VTGN Vistagen Therapeutics, Inc.
2.1850
+6.59%
NEUP Neuphoria Therapeutics Inc.
5.20
+2.97%
OTLC Oncotelic Therapeutics, Inc.
0.0535
+5.73%